In-Person EventMay 30 - Jun 10, 2016Barcelona, Cataluna, ES
Speakers
OVERVIEW
At the completion of this educational activity participants should be able to:
- Discuss the significance of addressing triglycerides and non-HDL abnormalities for reducing cardiovascular risk
- Identify medical factors, medications, insulin resistance as secondary causes of obesity and how to workup, address and treat these conditions
- Discuss practical approach to work up pediatric patients with dyslipidemia and discuss use of pharmaco therapy in youth and adolescents,
- Discuss outcomes data for CRP, ApoB, LDL-P, and cost effective approach to treatment of residual risk
- Describe the concept of concordance and discordance of LDL Cholesterol versus LDL Particle or ApoB and apply to management
- Describe work up and diagnosis of familial hypercholesterolemia and explain treatment approach inclusive of new therapies
- Diagnose PCOS and describe the approach to management
- Discuss state-of-the art Cardiovascular and Global Preventive Medicine Patients
- Differentiate Methods to Diagnose and Treat Resistant Hypertension
- Apply Primary and Secondary Cardiovascular Prevention Goals
- Explain Diagnostic, Treatment and Prevention Strategies for Alzheimer’s Disease and Vascular Dementia
- Analyze patients’ requirement for prevention and treatment of travel-related health problems
- Assess the pros and cons of omega-3 fatty acids for cardiovascular disease prevention and global health
- Discuss office-based treatment strategies for maximal reduction of cardiovascular residual risk